Healthcare - Sector
KLDO is currently covered by 1 analysts
Kaleido Biosciences's activity chart (see below) currently has 15 price targets and 11 ratings on display. The stock rating distribution of KLDO is 100% HOLD.
Analysts' price targets on this stock were met 40% of the time, taking 35.4 days on average.
Highest price target for KLDO is $2, Lowest price target is $2.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 04-Apr-2022. First documented stock forecast 25-Mar-2019.
Currently out of the existing stock ratings of KLDO, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$1.7
$3
4 years 7 months 17 days ago
(04-Apr-2022)
0/3 (0%)
$0.06 (3.66%)
Buy
$4
$19
4 years 9 months 24 days ago
(28-Jan-2022)
0/2 (0%)
$2.26 (129.89%)
Buy
$22
$22
5 years 18 days ago
(03-Nov-2021)
0/2 (0%)
$14.82 (247.54%)
Sell
$3
$8
5 years 1 months 1 days ago
(20-Oct-2021)
6/6 (100%)
$-1.56 (-34.21%)
78
Sell
$5
$10
5 years 5 months 5 days ago
(16-Jun-2021)
2/2 (100%)
$-0.55 (-9.42%)
99
What is KLDO (Kaleido Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on KLDO (Kaleido Biosciences)?
Which analyst has the lowest performance score on KLDO (Kaleido Biosciences) with a proven track record?
Which analyst has the most public recommendations on KLDO (Kaleido Biosciences)?
Which analyst is the currently most bullish on KLDO (Kaleido Biosciences)?
Which analyst is the currently most reserved on KLDO (Kaleido Biosciences)?